Diabetic Peripheral Neuropathy clinical trials

Explore recruiting diabetic peripheral neuropathy clinical trials.

Recruiting diabetic peripheral neuropathy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Diabetic Peripheral Neuropathy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study of the safety, tolerability, pharmacokinetics and preliminary efficacy of TNV108 in healthy adults and patients with diabetic peripheral neuropathy

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Efficacy and tolerability of ODM-111 in chronic pain due to diabetic peripheral neuropathy

Germany, Czechia, Bulgaria, Poland, Hungary

Therapeutic exploratory (Phase II) EU CTIS Study details

J2P-MC-LXBD: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Poland, Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Efficacy and safety of co-administered cagrilintide and semaglutide (CagriSema) once weekly versus placebo in participants with type 2 diabetes and painful diabetic peripheral neuropathy

Norway, Denmark, Spain, France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Painful Diabetic Peripheral Neuropathy

France, Italy, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double-blind, placebo-controlled study to assess the effects of high concentration capsaicin patch (Qutenza) on neuropathic symptoms, nerve fibers, and microcirculation in painful diabetic peripheral neuropathy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Diabetic Peripheral Neuropathy trials by city

Diabetic Peripheral Neuropathy in Toronto Diabetic Peripheral Neuropathy in Vancouver Diabetic Peripheral Neuropathy in Montreal Diabetic Peripheral Neuropathy in Calgary Diabetic Peripheral Neuropathy in Edmonton Diabetic Peripheral Neuropathy in Ottawa Diabetic Peripheral Neuropathy in Winnipeg Diabetic Peripheral Neuropathy in Quebec City Diabetic Peripheral Neuropathy in Hamilton Diabetic Peripheral Neuropathy in Kitchener Diabetic Peripheral Neuropathy in London Diabetic Peripheral Neuropathy in Halifax Diabetic Peripheral Neuropathy in New York Diabetic Peripheral Neuropathy in Los Angeles Diabetic Peripheral Neuropathy in Chicago Diabetic Peripheral Neuropathy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease